MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What Triggered GeneDx's Recent Stock Plunge

10 hours ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Triggered Robinhood's Recent Stock Plunge

3 months ago

What Triggered Sportradar's Recent Stock Plunge

1 months ago

What Triggered Livent's Recent Stock Plunge

3 months ago

What Triggered Doximity's Recent Stock Plunge

3 months ago

GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS

GeneDx Holdings (WGS) shares fell 49% on May 5, 2025, erasing $900 million in market value. The decline followed a Q1 2026 earnings miss, a tenfold increase in net losses, and a significant reduction ...

WGS

Stock News•1 months ago

Why GeneDX Stock Is Plummeting Today

GeneDX shares fell sharply following the release of its latest quarterly report. The decline reflects investor disappointment with the company's financial results and operational updates provided in t...

WGS

Stock News•1 months ago

GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel, PLLP has launched an investigation into GeneDx Holdings Corp. (NASDAQ: WGS) regarding potential federal securities law violations. The firm is evaluating whether executive officers mis...

WGS

Stock News•1 months ago

Will Robust Exome and Genome Revenues Lift GeneDx's Q1 Earnings?

GeneDx enters its Q1 earnings report with strong momentum in exome and genome testing revenues. The company's growth is driven by expanding clinical adoption and a competitive advantage in rare-diseas...

WGS